• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

F. Hoffmann-la Roche Ltd.

Headquarters: Basel, Switzerland
Website: N/A
Year Founded: 1996
Status: Out of Business

BioCentury | Mar 31, 2021
Regulation

March 31 Quick Takes: Basket of EU approvals includes MS, SMA drugs; plus Amarin, AbbVie, Cara-Vifor 

The European Commission approved Kesimpta ofatumumab from Novartis AG (NYSE:NVS; SIX:NOVN) to treat relapsing forms of multiple sclerosis. The subcutaneously administered drug was originally
BioCentury | Oct 19, 2018
Company News

Revolution acquiring Warp Drive

BioCentury | May 16, 2017
Distillery Therapeutics

Neurology

BioCentury | Apr 15, 2013
Company News

Human Genome Sciences, Roche deal

BioCentury | Apr 15, 2013
Clinical News

Insulin-like growth factor-1 data

BioCentury | Mar 4, 2013
Clinical News

Roche preclinical data

BioCentury | Feb 18, 2013
Company News

Chiasma, Novartis, Roche deal

BioCentury | Feb 18, 2013
Company News

Genentech, RQx Pharmaceuticals, Roche deal

Items per page:
1 - 10 of 336